Studies have demonstrated that berberine enhances cellular insulin sensitivity and ameliorates insulin resistance by modulating key components of the insulin signaling pathway—including InsR, IRS-1, AKT, and AMPK (Figure 2). This evidence concerns the gene AKT1 and Insulin resistance.